Cite
APA Citation
Yao, J. C., Strosberg, J., Fazio, N., Pavel, M. E., Bergsland, E., Ruszniewski, P., Halperin, D. M., Li, D., Tafuto, S., Raj, N., Campana, D., Hijioka, S., Raderer, M., Guimbaud, R., Gajate, P., Pusceddu, S., Reising, A., Degtyarev, E., Shilkrut, M., Eddy, S., & Singh, S. (2021). spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms. Endocrine-related cancer, 28(3), 161–172. http://access.bl.uk/ark:/81055/vdc_100130759879.0x000023